Correlation Between Pacira BioSciences, and Lantheus Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Lantheus Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Lantheus Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Lantheus Holdings, you can compare the effects of market volatilities on Pacira BioSciences, and Lantheus Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Lantheus Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Lantheus Holdings.

Diversification Opportunities for Pacira BioSciences, and Lantheus Holdings

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pacira and Lantheus is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Lantheus Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantheus Holdings and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Lantheus Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantheus Holdings has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Lantheus Holdings go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Lantheus Holdings

Given the investment horizon of 90 days Pacira BioSciences, is expected to under-perform the Lantheus Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Pacira BioSciences, is 1.05 times less risky than Lantheus Holdings. The stock trades about -0.01 of its potential returns per unit of risk. The Lantheus Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  7,308  in Lantheus Holdings on November 20, 2024 and sell it today you would earn a total of  686.00  from holding Lantheus Holdings or generate 9.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pacira BioSciences,  vs.  Lantheus Holdings

 Performance 
       Timeline  
Pacira BioSciences, 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.
Lantheus Holdings 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Lantheus Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pacira BioSciences, and Lantheus Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pacira BioSciences, and Lantheus Holdings

The main advantage of trading using opposite Pacira BioSciences, and Lantheus Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Lantheus Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantheus Holdings will offset losses from the drop in Lantheus Holdings' long position.
The idea behind Pacira BioSciences, and Lantheus Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities